Gyre Therapeutics (GYRE) Revenue (2010 - 2026)
Gyre Therapeutics (GYRE) posted Revenue of $29.11 million for Q2 2026, down 2.1% from $29.73 million a year earlier but up 29.2% from the prior quarter.
Gyre Therapeutics (GYRE) Revenue (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Gyre Therapeutics was $119.38 million, up 13.5% year-over-year; for FY2025, it was $116.59 million, up 10.2% from FY2024.
- Annual Revenue shows a five-year compound annual growth rate of 41.0% (FY2020 to FY2025).
- In prior years, Gyre Therapeutics' Revenue was $105.76 million in FY2024 (-6.8%), $113.45 million in FY2023 (+10.9%), $102.29 million in FY2022 and $7.34 million in FY2021 (-65.0%).
- Quarterly Revenue has run from a low of $794,000 in Q1 2022 to a high of $101.5 million in Q4 2022 over five years.
- On a year-over-year basis, Revenue increased in five of the last eight quarters, with growth averaging 4.3%.
- The strongest year-over-year quarter for Revenue in the past five years was Q3 2021, with growth of 157.4%; the weakest was Q4 2023, with a decline of 73.3%.
- According to Business Quant data, Revenue for the three prior quarters was $22.52 million (Q1 2026), $37.2 million (Q4 2025) and $30.56 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | 29.11 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.11 Mn |
| Mar 31, 2026 | 22.52 Mn |
| Dec 31, 2025 | 37.20 Mn |
| Sep 30, 2025 | 30.56 Mn |
| Jun 30, 2025 | 29.73 Mn |
| Mar 31, 2025 | 22.06 Mn |
| Dec 31, 2024 | 27.87 Mn |
| Sep 30, 2024 | 25.49 Mn |
| Jun 30, 2024 | 25.23 Mn |
| Mar 31, 2024 | 27.17 Mn |
| Dec 31, 2023 | 27.15 Mn |
| Sep 30, 2023 | 32.04 Mn |
| Jun 30, 2023 | 29.33 Mn |
| Mar 31, 2023 | 24.93 Mn |
| Dec 31, 2022 | 101.50 Mn |
| Mar 31, 2022 | 794,000.00 |
| Dec 31, 2021 | 2.44 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Jun 30, 2021 | 1.13 Mn |
| Mar 31, 2021 | 1.47 Mn |
Gyre Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=GYRE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();